Skip to main content

Animations

MJFF Publications

5871 - 5880 of 8587 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2018
  • 2013
  • 2019
  • 2022
  • 2021
  • 2024
  • 2022
  • 2023
  • Summary Details
    OPEN
    Title: Genetic architecture of subcortical brain structures in 38,851 individuals
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-019-0511-y
    Citation Count: 253
  • Summary Details
    OPEN
    Title: The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson’s Disease
    Journal Name: Aging, Neuropsychology, and Cognition
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/13825585.2019.1653445
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Herp depletion protects from protein aggregation by up-regulating autophagy
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.bbamcr.2013.09.006
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27772
    Best OA location URL:
    Citation Count: 37
  • Summary Details
    OPEN
    Title: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.15252/embj.2022112006
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28630
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae346
    Citation Count: 14
  • Summary Details
    OPEN
    Title: A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.79771
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29424
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.